RedHill Biopharma Provides Semi-Annual Business Update
Apr 09, 2018 11:00 am UTC| Business
TEL-AVIV, Israel and RALEIGH, N.C., April 09, 2018 -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on late...
Gopher Protocol Inc. Acquires Fintech Assets
Apr 09, 2018 11:00 am UTC| Business
Enhancing Financial Services Portfolio ATLANTA, GA, April 09, 2018 -- GOPHER PROTOCOL INC. (OTCQB: GOPH) ("Gopher"), a technology company which specializes in the creation of Internet of Things (IoT) and...
Gran Colombia Gold Continues to Report Growth in Its First Quarter 2018 Production Update
Apr 09, 2018 11:00 am UTC| Business
TORONTO, April 09, 2018 -- Gran Colombia Gold Corp. (TSX:GCM) announced today that it produced a total 18,633 ounces of gold in March bringing the total for the first quarter of 2018 to 52,672 ounces, up 35% compared to...
Akoustis Expands Commercial Product Portfolio with New 3.8 GHz BAW RF Filter
Apr 09, 2018 11:00 am UTC| Business
- Company’s second product manufactured using its high frequency XB1 Single Crystal BAW process -- High frequency solution aligns with emerging 5G frequency spectrum -- Company expects product qualification and release in...
NuCana plc Announces Appointment of Adam George to its Board of Directors
Apr 09, 2018 11:00 am UTC| Business
EDINBURGH, United Kingdom, April 09, 2018 -- NuCana plc (Nasdaq:NCNA), a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for cancer patients by applying its ProTide™...
BioVie Inc. (OTCQB:BIVI) Attains Milestone
Apr 09, 2018 11:00 am UTC| Business
BEVERLY, Mass., April 09, 2018 -- BioVie Inc. (OTCQB:BIVI), a clinical-stage company focused on the development and commercialization of innovative drug therapies for liver disease, announced today that it has achieved...
Tyme Provides Clinical and Corporate Update for Fiscal Year End 2018
Apr 09, 2018 11:00 am UTC| Business
NEW YORK, April 09, 2018 -- Tyme Technologies, Inc. (NASDAQ:TYME), a clinical-stage oncology company developing metabolically-based cancer therapeutics, today announced a clinical and corporate update for the fiscal...